RTOG Address
Search  
HomeMember InfoProtocolsResearcherMeetingsVisitorsFAQSite Map
January 2008 Study Summary Reports
AVAILABLE STUDY SUMMARY REPORTS

The following Study Summary Reports are now available in PDF (Adobe Acrobat) format:

  1. 0627 Phase II GBM
  2. 0625 Phase II Recurrent Glioblastoma
  3. 0623 Phase II SCLC(NEW)
  4. 0622 Phase II Samarium 153 High Risk Prostate(To be opened)
  5. 0621 Phase II Adjuvant 3DCRT/IMRT High Risk Prostate (To be opened)
  6. 0618 Phase II SBRT(NEW)
  7. 0617 Phase III NSCLC
  8. 0615 Phase II Nasopharyngeal
  9. 0614 Phase III Whole Brain Radiotherapy(To be opened)
  10. 0612 Prostate DNA Microarray
  11. 0611 GBM VEGF/MMP POST-RT
  12. 0534 Phase III Post-op Prostate
  13. 0529 Phase II Anal Canal
  14. 0526 Phase II Prostate Brachy
  15. 0526 Phase II Prostate Brachy(LATE)
  16. 0525 Phase III GBM
  17. 0524 Phase I/II Bladder(LATE)
  18. 0522 Phase III Advanced H & N
  19. 0521 Phase III Prostate
  20. 0518 Phase III OSTEOPOROSIS RISK
  21. 0517 Palliation Bone Mets
  22. 0515 NSCLC PET FUSION
  23. 0514 H&N Cancer Tissue/Specimen Bank
  24. 0513 Phase II GBM(LATE)
  25. 0438 Phase I Liver(LATE)
  26. 0436 Phase III Esophageal Cancer
  27. 0435 Phase III PALIFERIN/MUCOSITIS
  28. 0433 Phase III Re-irradiation
  29. 0424 Phase II High Risk Low-Grade Gliomas
  30. 0421 Phase III Head & Neck
  31. 0418 Phase II IMRT ENDO/CERVIX
  32. 0417 Phase II Cervix/Bevacizumab(LATE)
  33. 0415 Phase III Hypofractionation
  34. 0413 Phase III Breast
  35. 0412 Phase III Lung
  36. 0330 Phase II Sarcoma
  37. 0321 Phase II Prostate
  38. 0321 Phase II Prostate(LATE)
  39. 0320 Phase III
  40. 0247 Phase II Rectal Cancer
  41. 0244 Phase II Head & Neck Phase II Salivary
  42. 0239 Phase II Lung
  43. 0236 Phase II Lung
  44. 0235 ACRIN 6668/RTOG 0235(NEW)
  45. 0234 Phase II Head and Neck
  46. 0233 Phase II Bladder/Chemotherapy + RT
  47. 0232 Phase III Prostate
  48. 0229 Phase II Lung
  49. 0227 Phase I/II CNS Lymphoma
  50. 0214 Phase III Lung Prophylactic Cranial RT
  51. 0213 Phase I/II Lung
  52. 0212 Phase I/II Lung Prophylactic Cranial RT
  53. 0132 Phase II Gleevec (STI-571)/Gist
  54. 0129 Phase III Head and Neck
  55. 0127 Phase III Lung
  56. 0126 Phase III Prostate
  57. 0123 Phase II Lung(LATE)
  58. 0122 Cancer Cachexia
  59. 0117 Phase I/II Lung: 3D-CRT/Chemo
  60. 0015 Phase III Lung
  61. 9910 Phase III Prostate
  62. 9909 Phase II Post Op Immunotherapy/RT
  63. 9902 Phase III Prostate
  64. 9813 Phase III Anaplastic Astrocytoma
  65. 9813 DMC Efficacy report
  66. 9804 Phase III Breast DCIS
  67. 9601 Phase III Prostatectomy
  68. 9408 Phase III Prostate


 RTOG ENDORSED STUDY SUMMARY REPORTS

The following Endorsed Study Summary Reports are now available in PDF (Adobe Acrobat) format:

  1. CALBG 80101 Gastroesophageal Adenocarcinoma
  2. ECOG 4201 Pancreas
  3. MDA-3410 Prostate
  4. NCIC CTG JPR.7 Prostate
  5. NCIC CTG MA.20 Breast
  6. NCCTG N0574